Conference Call

  • First BanCorp to Report Q2 2025 Earnings on July 22 Markets

    First BanCorp to Report Q2 2025 Earnings on July 22

    First BanCorp (FBP) will release its Q2 2025 financial results on July 22, 2025, followed by a conference call and webcast at 10:00 AM ET. The presentation will be accessible via the company’s investor relations website. Replays will be available via telephone and on the website until August 21, 2025, and July 22, 2026, respectively. First BanCorp, through FirstBank Puerto Rico, operates in Puerto Rico, the U.S., British Virgin Islands, and Florida.

    2025年6月10日
  • Trevi Therapeutics Announces Phase 2b CORAL Trial Topline Results for Haduvio in IPF Chronic Cough: Conference Call and Webcast Scheduled for June 2nd Markets

    Trevi Therapeutics Announces Phase 2b CORAL Trial Topline Results for Haduvio in IPF Chronic Cough: Conference Call and Webcast Scheduled for June 2nd

    Trevi Therapeutics will release topline results from its Phase 2b CORAL trial of Haduvio, an investigational therapy for chronic cough in idiopathic pulmonary fibrosis (IPF). A conference call and webcast will be held on June 2nd, 2025, at 8:30 a.m. ET to discuss the findings. Haduvio targets the cough reflex arc, and initial trials show promising reduction in cough frequency. The results are highly anticipated as there is currently no approved therapy for IPF chronic cough. Further information can be found on the company’s website.

    2025年6月1日